2Seventy Ebitda vs Other Operating Expenses Analysis

TSVT Stock

USD 3.75 0.14 3.88%

2Seventy Bio financial indicator trend analysis is way more than just evaluating 2Seventy Bio prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether 2Seventy Bio is a good investment. Please check the relationship between 2Seventy Bio Ebitda and its Other Operating Expenses accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in 2Seventy Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For more information on how to buy 2Seventy Stock please use our How to Invest in 2Seventy Bio guide.

Ebitda vs Other Operating Expenses

Ebitda vs Other Operating Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of 2Seventy Bio Ebitda account and Other Operating Expenses. At this time, the significance of the direction appears to have pay attention.

The correlation between 2Seventy Bio's Ebitda and Other Operating Expenses is -0.79. Overlapping area represents the amount of variation of Ebitda that can explain the historical movement of Other Operating Expenses in the same time period over historical financial statements of 2Seventy Bio, assuming nothing else is changed. The correlation between historical values of 2Seventy Bio's Ebitda and Other Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebitda of 2Seventy Bio are associated (or correlated) with its Other Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Operating Expenses has no effect on the direction of Ebitda i.e., 2Seventy Bio's Ebitda and Other Operating Expenses go up and down completely randomly.

Correlation Coefficient

-0.79

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Ebitda

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of 2Seventy Bio. It is also known as 2Seventy Bio overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most indicators from 2Seventy Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into 2Seventy Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in 2Seventy Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For more information on how to buy 2Seventy Stock please use our How to Invest in 2Seventy Bio guide.Selling General Administrative is likely to gain to about 86.4 M in 2024, whereas Tax Provision is likely to drop 0.00 in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	52.0M	65.3M	98.3M	101.4M
Total Revenue	54.5M	91.5M	100.4M	108.8M

Gross Profit Total Revenue

2Seventy Bio fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Good Will	Non Current Liabilities Total	Capital Lease Obligations	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital
Common Stock Shares Outstanding		0.57	0.7	-0.71	-0.84	0.63	-0.86	0.74	0.48	0.48	-0.64	-0.65	0.68	0.27	-0.1	0.85	0.64	0.59	-0.77	0.6	0.7	-0.5	-0.72	0.84	0.4	0.63
Total Assets	0.57		0.99	-0.33	-0.57	0.99	-0.83	0.96	0.95	0.06	-0.96	-0.83	0.98	0.92	0.58	0.43	0.99	0.93	-0.74	1.0	0.99	-0.98	-0.82	0.86	0.96	0.99
Short Long Term Debt Total	0.7	0.99		-0.41	-0.65	0.99	-0.9	0.98	0.93	0.15	-0.96	-0.84	0.99	0.86	0.5	0.54	0.99	0.93	-0.8	0.99	1.0	-0.95	-0.87	0.92	0.92	0.99
Other Current Liab	-0.71	-0.33	-0.41		0.93	-0.38	0.63	-0.46	-0.41	-0.46	0.53	0.68	-0.48	-0.16	0.52	-0.71	-0.36	-0.39	0.78	-0.36	-0.41	0.31	0.35	-0.67	-0.15	-0.38
Total Current Liabilities	-0.84	-0.57	-0.65	0.93		-0.63	0.81	-0.69	-0.59	-0.29	0.69	0.85	-0.68	-0.34	0.2	-0.78	-0.6	-0.67	0.83	-0.58	-0.65	0.51	0.64	-0.82	-0.36	-0.63
Total Stockholder Equity	0.63	0.99	0.99	-0.38	-0.63		-0.85	0.98	0.94	0.04	-0.96	-0.87	0.98	0.89	0.55	0.46	1.0	0.95	-0.75	0.99	0.99	-0.97	-0.84	0.87	0.93	1.0
Other Liab	-0.86	-0.83	-0.9	0.63	0.81	-0.85		-0.87	-0.83	-0.4	0.86	0.77	-0.9	-0.62	-0.19	-0.85	-0.85	-0.85	0.92	-0.85	-0.9	0.75	0.91	-0.99	-0.74	-0.85
Net Tangible Assets	0.74	0.96	0.98	-0.46	-0.69	0.98	-0.87		0.87	0.12	-0.95	-0.88	0.97	0.81	0.45	0.51	0.99	0.91	-0.77	0.97	0.98	-0.94	-0.82	0.89	0.86	0.98
Property Plant And Equipment Net	0.48	0.95	0.93	-0.41	-0.59	0.94	-0.83	0.87		0.13	-0.96	-0.82	0.95	0.93	0.47	0.47	0.92	0.91	-0.81	0.96	0.93	-0.94	-0.78	0.86	0.94	0.94
Current Deferred Revenue	0.48	0.06	0.15	-0.46	-0.29	0.04	-0.4	0.12	0.13		-0.23	0.04	0.2	0.02	-0.58	0.59	0.07	-0.1	-0.59	0.12	0.15	-0.07	-0.07	0.43	0.12	0.04
Net Debt	-0.64	-0.96	-0.96	0.53	0.69	-0.96	0.86	-0.95	-0.96	-0.23		0.88	-0.99	-0.9	-0.35	-0.51	-0.96	-0.88	0.87	-0.97	-0.96	0.97	0.75	-0.91	-0.91	-0.96
Accounts Payable	-0.65	-0.83	-0.84	0.68	0.85	-0.87	0.77	-0.88	-0.82	0.04	0.88		-0.86	-0.7	-0.25	-0.47	-0.84	-0.88	0.75	-0.83	-0.84	0.81	0.7	-0.81	-0.67	-0.87
Cash	0.68	0.98	0.99	-0.48	-0.68	0.98	-0.9	0.97	0.95	0.2	-0.99	-0.86		0.89	0.43	0.54	0.98	0.92	-0.85	0.99	0.99	-0.96	-0.82	0.93	0.93	0.98
Non Current Assets Total	0.27	0.92	0.86	-0.16	-0.34	0.89	-0.62	0.81	0.93	0.02	-0.9	-0.7	0.89		0.6	0.15	0.89	0.79	-0.62	0.92	0.86	-0.96	-0.58	0.68	0.97	0.89
Non Currrent Assets Other	-0.1	0.58	0.5	0.52	0.2	0.55	-0.19	0.45	0.47	-0.58	-0.35	-0.25	0.43	0.6		-0.22	0.56	0.57	0.08	0.54	0.5	-0.54	-0.49	0.15	0.63	0.55
Other Assets	0.85	0.43	0.54	-0.71	-0.78	0.46	-0.85	0.51	0.47	0.59	-0.51	-0.47	0.54	0.15	-0.22		0.45	0.52	-0.8	0.46	0.54	-0.3	-0.73	0.81	0.32	0.46
Cash And Short Term Investments	0.64	0.99	0.99	-0.36	-0.6	1.0	-0.85	0.99	0.92	0.07	-0.96	-0.84	0.98	0.89	0.56	0.45		0.93	-0.74	0.99	0.99	-0.97	-0.83	0.87	0.93	1.0
Net Receivables	0.59	0.93	0.93	-0.39	-0.67	0.95	-0.85	0.91	0.91	-0.1	-0.88	-0.88	0.92	0.79	0.57	0.52	0.93		-0.7	0.92	0.93	-0.86	-0.92	0.84	0.84	0.95
Good Will	-0.77	-0.74	-0.8	0.78	0.83	-0.75	0.92	-0.77	-0.81	-0.59	0.87	0.75	-0.85	-0.62	0.08	-0.8	-0.74	-0.7		-0.78	-0.8	0.71	0.69	-0.96	-0.68	-0.75
Non Current Liabilities Total	0.6	1.0	0.99	-0.36	-0.58	0.99	-0.85	0.97	0.96	0.12	-0.97	-0.83	0.99	0.92	0.54	0.46	0.99	0.92	-0.78		0.99	-0.98	-0.82	0.88	0.96	0.99
Capital Lease Obligations	0.7	0.99	1.0	-0.41	-0.65	0.99	-0.9	0.98	0.93	0.15	-0.96	-0.84	0.99	0.86	0.5	0.54	0.99	0.93	-0.8	0.99		-0.95	-0.87	0.92	0.92	0.99
Inventory	-0.5	-0.98	-0.95	0.31	0.51	-0.97	0.75	-0.94	-0.94	-0.07	0.97	0.81	-0.96	-0.96	-0.54	-0.3	-0.97	-0.86	0.71	-0.98	-0.95		0.69	-0.8	-0.96	-0.97
Other Current Assets	-0.72	-0.82	-0.87	0.35	0.64	-0.84	0.91	-0.82	-0.78	-0.07	0.75	0.7	-0.82	-0.58	-0.49	-0.73	-0.83	-0.92	0.69	-0.82	-0.87	0.69		-0.86	-0.73	-0.84
Other Stockholder Equity	0.84	0.86	0.92	-0.67	-0.82	0.87	-0.99	0.89	0.86	0.43	-0.91	-0.81	0.93	0.68	0.15	0.81	0.87	0.84	-0.96	0.88	0.92	-0.8	-0.86		0.77	0.87
Total Liab	0.4	0.96	0.92	-0.15	-0.36	0.93	-0.74	0.86	0.94	0.12	-0.91	-0.67	0.93	0.97	0.63	0.32	0.93	0.84	-0.68	0.96	0.92	-0.96	-0.73	0.77		0.93
Net Invested Capital	0.63	0.99	0.99	-0.38	-0.63	1.0	-0.85	0.98	0.94	0.04	-0.96	-0.87	0.98	0.89	0.55	0.46	1.0	0.95	-0.75	0.99	0.99	-0.97	-0.84	0.87	0.93

Click cells to compare fundamentals

2Seventy Bio Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for 2Seventy Stock Analysis

When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

2Seventy Ebitda vs Other Operating Expenses Analysis

Ebitda vs Other Operating Expenses

Ebitda vs Other Operating Expenses Correlation Analysis

Correlation Coefficient

Ebitda

Other Operating Expenses

2Seventy Bio fundamental ratios Correlations

2Seventy Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for 2Seventy Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Liabilities Total	+ 1.0	Total Assets
Capital Lease Obligations	+ 1.0	Short Long Term Debt Total
Cash And Short Term Investments	+ 1.0	Total Stockholder Equity
Net Invested Capital	+ 1.0	Total Stockholder Equity
Net Invested Capital	+ 1.0	Cash And Short Term Investments
Short Long Term Debt Total	+ 0.99	Total Assets

Cash	- 0.99	Net Debt
Other Stockholder Equity	- 0.99	Other Liab
Inventory	- 0.98	Non Current Liabilities Total
Inventory	- 0.98	Total Assets
Net Invested Capital	- 0.97	Inventory
Inventory	- 0.97	Cash And Short Term Investments